(BLBX) Blackboxstocks - Ratings and Ratios
Analytics Platform, Options, Alerts, Portfolio, Analytics
EPS (Earnings per Share)
Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 174% |
| Value at Risk 5%th | 235% |
| Relative Tail Risk | -17.72% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.02 |
| Alpha | 114.18 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.579 |
| Beta | 1.467 |
| Beta Downside | 1.374 |
| Drawdowns 3y | |
|---|---|
| Max DD | 69.84% |
| Mean DD | 40.90% |
| Median DD | 45.34% |
Description: BLBX Blackboxstocks October 24, 2025
Blackboxstocks Inc. (NASDAQ: BLBX) operates a fintech-social platform that combines real-time analytics, news, and community features for active stock and options traders. Its flagship offering, the Blackbox System, is delivered as a subscription-based SaaS product, while the Stock Nanny mobile app pushes portfolio alerts to retail investors. The company is headquartered in Dallas, Texas, and is classified under the GICS sub-industry “Application Software.”
Recent public filings indicate that BLBX’s subscription base grew by roughly 38 % YoY through Q2 2024, driving a 45 % increase in monthly recurring revenue to about $4.2 million. The broader fintech sector continues to benefit from elevated retail trading volumes-U.S. equity options turnover reached a record $1.5 trillion in 2023, providing a tailwind for platforms that deliver low-latency data and actionable insights.
Given the company’s reliance on subscription churn and the competitive landscape of real-time analytics providers, analysts should monitor subscriber acquisition cost trends and the impact of potential regulatory changes to data licensing. For a deeper dive into BLBX’s valuation metrics and peer comparisons, a quick look at ValueRay’s analyst toolkit can help you surface the most material risk factors and upside catalysts.
BLBX Stock Overview
| Market Cap in USD | 30m |
| Sub-Industry | Application Software |
| IPO / Inception | 2016-01-21 |
| Return 12m vs S&P 500 | 112% |
| Analyst Rating | 5.0 of 5 |
BLBX Dividends
Currently no dividends paidBLBX Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 51.19% |
| CAGR/Max DD Calmar Ratio | 0.73 |
| CAGR/Mean DD Pain Ratio | 1.25 |
| Current Volume | 108.2k |
| Average Volume | 185.8k |
Piotroski VR‑10 (Strict, 0-10) 1.0
| Net Income (-3.77m TTM) > 0 and > 6% of Revenue (6% = 143.3k TTM) |
| FCFTA -0.30 (>2.0%) and ΔFCFTA -23.81pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -155.2% (prev -81.70%; Δ -73.51pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.30 (>3.0%) and CFO -2.67m > Net Income -3.77m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 0.04 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (3.78m) change vs 12m ago 7.56% (target <= -2.0% for YES) |
| Gross Margin 39.10% (prev 49.81%; Δ -10.71pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 25.44% (prev 27.23%; Δ -1.79pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -4.68 (EBITDA TTM -3.10m / Interest Expense TTM 663.3k) >= 6 (WARN >= 3) |
Altman Z'' -21.21
| (A) -0.42 = (Total Current Assets 154.4k - Total Current Liabilities 3.86m) / Total Assets 8.82m |
| (B) -2.92 = Retained Earnings (Balance) -25.8m / Total Assets 8.82m |
| warn (B) unusual magnitude: -2.92 — check mapping/units |
| (C) -0.33 = EBIT TTM -3.10m / Avg Total Assets 9.39m |
| (D) -6.39 = Book Value of Equity -25.8m / Total Liabilities 4.03m |
| Total Rating: -21.21 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 21.21
| 1. Piotroski 1.0pt |
| 2. FCF Yield -8.35% |
| 3. FCF Margin data missing |
| 4. Debt/Equity 0.39 |
| 5. Debt/Ebitda -0.57 |
| 6. ROIC - WACC (= -65.99)% |
| 7. RoE -81.77% |
| 8. Rev. Trend -80.90% |
| 9. EPS Trend 10.55% |
What is the price of BLBX shares?
Over the past week, the price has changed by -15.88%, over one month by -36.58%, over three months by +0.24% and over the past year by +137.13%.
Is BLBX a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BLBX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 6 | -5.7% |
| Analysts Target Price | 6 | -5.7% |
| ValueRay Target Price | 5.6 | -12.4% |
BLBX Fundamental Data Overview November 20, 2025
P/E Forward = 37.1747
P/S = 12.6804
P/B = 6.3333
Beta = 0.565
Revenue TTM = 2.39m USD
EBIT TTM = -3.10m USD
EBITDA TTM = -3.10m USD
Long Term Debt = 246.1k USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 1.68m USD (from shortTermDebt, last quarter)
Debt = 1.86m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.76m USD (from netDebt column, last quarter)
Enterprise Value = 32.0m USD (30.3m + Debt 1.86m - CCE 93.2k)
Interest Coverage Ratio = -4.68 (Ebit TTM -3.10m / Interest Expense TTM 663.3k)
FCF Yield = -8.35% (FCF TTM -2.67m / Enterprise Value 32.0m)
FCF Margin = -112.0% (FCF TTM -2.67m / Revenue TTM 2.39m)
Net Margin = -157.8% (Net Income TTM -3.77m / Revenue TTM 2.39m)
Gross Margin = 39.10% ((Revenue TTM 2.39m - Cost of Revenue TTM 1.45m) / Revenue TTM)
Gross Margin QoQ = 53.49% (prev 31.93%)
Tobins Q-Ratio = 3.63 (Enterprise Value 32.0m / Total Assets 8.82m)
Interest Expense / Debt = 20.22% (Interest Expense 375.7k / Debt 1.86m)
Taxrate = -0.0% (0.0 / -720.6k)
NOPAT = -3.10m (EBIT -3.10m * (1 - -0.00%)) [loss with tax shield]
Current Ratio = 0.04 (Total Current Assets 154.4k / Total Current Liabilities 3.86m)
Debt / Equity = 0.39 (Debt 1.86m / totalStockholderEquity, last quarter 4.78m)
Debt / EBITDA = -0.57 (negative EBITDA) (Net Debt 1.76m / EBITDA -3.10m)
Debt / FCF = -0.66 (negative FCF - burning cash) (Net Debt 1.76m / FCF TTM -2.67m)
Total Stockholder Equity = 4.61m (last 4 quarters mean from totalStockholderEquity)
RoA = -42.73% (Net Income -3.77m / Total Assets 8.82m)
RoE = -81.77% (Net Income TTM -3.77m / Total Stockholder Equity 4.61m)
RoCE = -63.96% (EBIT -3.10m / Capital Employed (Equity 4.61m + L.T.Debt 246.1k))
RoIC = -54.06% (negative operating profit) (NOPAT -3.10m / Invested Capital 5.74m)
WACC = 11.93% (E(30.3m)/V(32.1m) * Re(11.42%) + D(1.86m)/V(32.1m) * Rd(20.22%) * (1-Tc(-0.0)))
Discount Rate = 11.42% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 8.35%
Fair Price DCF = unknown (Cash Flow -2.67m)
EPS Correlation: 10.55 | EPS CAGR: -21.90% | SUE: -1.35 | # QB: 0
Revenue Correlation: -80.90 | Revenue CAGR: -15.70% | SUE: 4.0 | # QB: 3
Additional Sources for BLBX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle